BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
21 February 2019 - 11:45PM
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly
growing commercial stage specialty pharmaceutical company dedicated
to patients living with chronic pain, today announced that it will
report its fourth quarter and full year 2018 financial results
after the close of the U.S. financial markets on Thursday, March
14, 2019. The company will host a conference call at 4:30 PM
Eastern Time to discuss the results and provide an update on
business operations.
Conference Call Dial In & Webcast
Information:
Date: |
Thursday, March 14, 2019 |
Time: |
4:30 PM Eastern Time |
Domestic: |
877-407-0789 |
International: |
201-689-8562 |
Passcode: |
13687656 |
Webcast: |
http://public.viavid.com/index.php?id=133294 |
About BioDelivery Sciences International,
Inc.BioDelivery Sciences International, Inc. (NASDAQ:
BDSI) is a rapidly growing commercial-stage specialty
pharmaceutical company dedicated to patients living with chronic
pain. BDSI is utilizing its novel and proprietary BioErodible
MucoAdhesive (BEMA®) technology and other drug delivery
technologies to develop and commercialize, either on its own or in
partnership with third parties, new applications of proven
therapies aimed at addressing important unmet medical needs. BDSI's
marketed products and those in development address serious and
debilitating conditions such as chronic pain, breakthrough cancer
pain, and opioid dependence. For more information, please visit us
at www.bdsi.com or follow us
on Facebook.com/BioDeliverySI or Twitter BDSI
@BioDeliverySI.
Mary Coleman 919-582-0188mcoleman@bdsi.com
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Apr 2024 to May 2024
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about BioDelivery Sciences International Inc (NASDAQ): 0 recent articles
More News Articles